Skip to main content
Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: Impact of metabolic syndrome and metabolic dysfunction-associated fatty liver disease on cardiovascular risk by the presence or absence of type 2 diabetes and according to sex

Fig. 1

Distribution of participants according to the presence or absence of metabolic dysfunction-associated fatty liver disease (MAFLD), metabolic syndrome (MetS), and type 2 diabetes (DM). A Distribution of total participant population according to the presence or absence of MAFLD, MetS, and DM. B Distribution of women according to the presence or absence of MAFLD, MetS, and DM. C Distribution of men according to the presence or absence of MAFLD, MetS, and DM

Back to article page